The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection EM Gardner, MP McLees, JF Steiner, C Del Rio, WJ Burman Clinical infectious diseases 52 (6), 793-800, 2011 | 2216 | 2011 |
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial SP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ... The Lancet 372 (9653), 1881-1893, 2008 | 1986 | 2008 |
Mild or moderate Covid-19 RT Gandhi, JB Lynch, C Del Rio New England journal of medicine 383 (18), 1757-1766, 2020 | 1746 | 2020 |
COVID-19—new insights on a rapidly changing epidemic C Del Rio, PN Malani Jama 323 (14), 1339-1340, 2020 | 924 | 2020 |
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection J Wrammert, D Koutsonanos, GM Li, S Edupuganti, J Sui, M Morrissey, ... Journal of Experimental Medicine 208 (1), 181-193, 2011 | 916 | 2011 |
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 912 | 2022 |
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ... Jama 316 (2), 191-210, 2016 | 840 | 2016 |
Long-term health consequences of COVID-19 C Del Rio, LF Collins, P Malani Jama 324 (17), 1723-1724, 2020 | 724 | 2020 |
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ... Jama 320 (4), 379-396, 2018 | 712 | 2018 |
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines JD Miller, RG van der Most, RS Akondy, JT Glidewell, S Albott, ... Immunity 28 (5), 710-722, 2008 | 669 | 2008 |
Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care LI Gardner, LR Metsch, P Anderson-Mahoney, AM Loughlin, C Del Rio, ... Aids 19 (4), 423-431, 2005 | 528 | 2005 |
2019 novel coronavirus—important information for clinicians C Del Rio, PN Malani Jama 323 (11), 1039-1040, 2020 | 493 | 2020 |
Cabotegravir for HIV prevention in cisgender men and transgender women RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ... New England Journal of Medicine 385 (7), 595-608, 2021 | 474 | 2021 |
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ... Jama 324 (16), 1651-1669, 2020 | 449 | 2020 |
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. Centers for Disease Control and Prevention (CDC MMWR: Morbidity & Mortality Weekly Report 61 (31), 2012 | 393 | 2012 |
Safety of influenza vaccination during pregnancy PD Tamma, KA Ault, C del Rio, MC Steinhoff, NA Halsey, SB Omer American journal of obstetrics and gynecology 201 (6), 547-552, 2009 | 372 | 2009 |
Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. C Del Rio, G Hall, EW Hook Iii, KK Holmes, WLH Whittington, FN Judson, ... JAMA: Journal of the American Medical Association 297 (22), 2007 | 371 | 2007 |
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response RS Akondy, ND Monson, JD Miller, S Edupuganti, D Teuwen, H Wu, ... The Journal of Immunology 183 (12), 7919-7930, 2009 | 364 | 2009 |
The COVID-19 pandemic in the US: a clinical update SB Omer, P Malani, C Del Rio Jama 323 (18), 1767-1768, 2020 | 313 | 2020 |
Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial SP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ... Lancet 372 (9653), 1881-1893, 2008 | 306 | 2008 |